AI tool accurately predicts colorectal cancer aggressiveness, patient survival outcomes

An artificial intelligence tool developed at Harvard Medical School and National Cheng Kung University in Taiwan correctly predicted the aggressiveness of colorectal cancer.The tool, named MOMA (Multi-omics Multi-cohort Assessment), evaluates microscopic images of tumor samples to predict cancer aggressiveness, the likelihood of survival with or without recurrence, and actionable genomic mutations in colorectal cancer.“There are two major things we can do with our published models — one is to tailor treatments based on the aggressiveness of the tumor as informed by our AI model,”Read More